Independent guide
Compounded Semaglutide Explained
Compounded semaglutide is a patient-specific preparation under applicable compounding law, not an FDA-approved branded or generic drug.
Health information: This article is educational, not medical advice. FDA-approved branded medicines and compounded preparations are different regulatory categories. Treatment choice and prescribing require an appropriate clinician.
Core facts
FDA does not pre-approve compounded drugs for safety, effectiveness or quality.
Section 503A compounding conditions include patient-specific prescription requirements and restrictions on regularly making essentially copies of commercially available drugs.
What to verify
Dosing instructions can differ by concentration and presentation, so use the prescription and pharmacy instructions.
Verify the pharmacy, ingredients, storage instructions and clinical follow-up.
Sources
- HealthRX pricing
- HealthRX FAQ
- FDA: concerns with unapproved GLP-1 drugs
- FDA: 2026 compounding policy clarification
- FDA Wegovy prescribing information
- FDA Zepbound prescribing information
Provider prices and policies can change. We date-check unstable facts and distinguish provider claims from FDA or prescribing-information sources.